PubMed · 2021 · 32 citations · 49 references
Open access
MedicineCancer BiologyOncologyChemotherapyMetabolismMetastasisCancer MetabolismCellular Energy MetabolismEnergy MetabolismMetabolic ReprogrammingMetabolic Reprogramming In CancerOxidative PhosphorylationAerobic GlycolysisEnergy Metabolism RegulationGlycolysis In Cancer MetabolismMetabolic Alterations In CancerOvarian Cancer MetastasisTumor Cell MetabolismTumor MetabolismWarburg Effect
), and invasiveness. Current knowledge acknowledges glycolysis to be the main energy provider in ovarian cancer growth, invasion, migration, and viability, so specific agents targeting the glycolysis or OXPHOS pathways have been used in previous studies to attenuate tumor progression and increase chemosensitization. However, chemoresistant cell lines exert various metabolic preferences. This review comprehensively summarizes the information from existing reports which could together provide an in-depth understanding and insights for the development of a novel targeted therapy which can be used as an adjunctive treatment to standard chemotherapy to decelerate tumor progression and decrease the epithelial ovarian cancer mortality rate.
49
Otto Warbürg · Science · 1956 · 13.3K citations
APM Heintz, Franco Odicino, Patrick Maisonneuve et al. · International Journal of Gynecology & Obstetrics · 2006 · 1.3K citations
Medicine, Gynecology, Oncology +10
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
William W. Wheaton, Samuel E. Weinberg, Robert B. Hamanaka et al. · eLife · 2014 · 1.1K citations · Full text
Clinical characteristics of clear cell carcinoma of the ovary
Toru Sugiyama, Toshiharu Kamura, Junzo Kigawa et al. · Cancer · 2000 · 804 citations